Patient Support Services Contact Us

Investors

Snapshot

Revenue & Earnings

Revenue (FY) --
EBIT (Mil) (FY) $-200.52
EBIT (Mil) (MRQ) $51.84
EBIT (Mil) (TTM) $2.23
EBITDA (Mil) (FY) $-197.28
EBITDA (Mil) (MRQ) $52.68
EBITDA (Mil) (TTM) $5.05
Net Income Excluding Extraordinary Items (Mil) (FY) $-209.34
Net Income Including Extraordinary Items (Mil) (FY) $-209.34
Diluted EPS Excluding Extraordinary Items (FY) $-3.22
Diluted EPS Including Extraordinary Items (FY) $-3.22

Dividends

Yield (%) --
Dividend Record Date
Dividend Rate --%

Ratios

Price to Revenue (TTM) $5.73
Price to Revenue (MRQ) $2.97
Price to Revenue (FY) --
Price To Cash Flow (TTM) --
Price to Cash Flow (MRQ) $6.92
Price to Cash Flow (FY) --
Price to Book (MRQ) $23.72
Price to Book (FY) --
Total Debt to Equity (MRQ) (%) 317.32%
Total Debt to Equity (FY) (%) --%
Current Ratio (MRQ) $3.34
Current Ratio (FY) $2.54

Growth

5-Year Annual Dividend Growth Rate (%) --%
5-Year Annual Revenue Growth Rate (%) --%

FY = Fiscal Year. MRQ = Most Recent Quarter. mil = Millions. TTM = Trailing Twelve Months.

Copyright Thomson Reuters Corporation